The latest news from Arcinova
Gareth Jenkins presenting at "Reopening laboratories: sharing best practice"Gareth Jenkins presenting at "Reopening laboratories: sharing best practice" About this Event The nationwide lockdown due to the spread of COVID saw an impressive
Arcinova appoints new Non-Executive DirectorArcinova appoints new Non-Executive Director “Internationally renowned Industry veteran Steve Bagshaw joins Arcinova board to propel continued industry-leading growth” Arcinova
Nathalie Huther Featured In European Biotechnology Magazine_aNathalie Huther Featured In European Biotechnology Magazine Did you see Nathalie’s quote on why she chose to work in Biotechnology in the latest summer edition of
The Growing Popularity of Capsule Manufacturing in PharmaOur Head of Drug Product and Scientific Direction, Steve Byard, recently shared his thoughts on the benefits of capsule manufacturing. In his article for PMPS, Steve explains the factors that must
OBN Events in conjunction with Arcinova presents "The Need for Speed: Gaining the right support to accelerate your small molecule candidate"OBN Events in conjunction with Arcinova presents "The Need for Speed: Gaining the right support to accelerate your small molecule candidate" About the EventThis digi
Dr. Nathalie Huther interviewed for Chemicals Knowledge Hub TVOur Senior Director of Business Development Europe, Dr. Nathalie Huther, was recently interviewed by journalist and presenter, David McClelland, for Chemicals Knowledge Hub TV! Watch the video to
Revving Up for the Revolution: Industry 4.0Revving Up for the Revolution: Industry 4.0 “The current change – from the third to the fourth industrial revolution – is marked by a move toward a consolidated, full-spectrum, data-driven a
Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical successRegister now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success Preformulation characterization of new chemical entities (NCE) can be c
Paul Quigley joins advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to ProductWe are thrilled to announce that our Head of Drug Substance, Paul Quigley, has been invited to join the advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product.
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.